0001209191-16-133601.txt : 20160721
0001209191-16-133601.hdr.sgml : 20160721
20160721160817
ACCESSION NUMBER: 0001209191-16-133601
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160719
FILED AS OF DATE: 20160721
DATE AS OF CHANGE: 20160721
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: bluebird bio, Inc.
CENTRAL INDEX KEY: 0001293971
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 SECOND STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 150 SECOND STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
FORMER COMPANY:
FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc
DATE OF NAME CHANGE: 20040616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Eric
CENTRAL INDEX KEY: 0001601797
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35966
FILM NUMBER: 161777500
MAIL ADDRESS:
STREET 1: GOODWIN PROCTER LLP
STREET 2: 53 STATE ST
CITY: BOSTON
STATE: MA
ZIP: 02109
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-07-19
0
0001293971
bluebird bio, Inc.
BLUE
0001601797
Sullivan Eric
C/O BLUEBIRD BIO, INC.
150 SECOND STREET
CAMBRIDGE
MA
02141
0
1
0
0
Principal Accounting Officer
Common Stock
2016-07-19
4
S
0
857
45.40
D
4656
D
Common Stock
2016-07-20
4
S
0
1849
44.8521
D
2807
D
Common Stock
2016-07-20
4
S
0
101
45.3351
D
2706
D
Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016.
The range in prices for the transaction reported on this line was $44.30 to $45.30. The average weighted price was $44.8521. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range in prices for the transaction reported on this line was $45.32 to $45.35. The average weighted price was $45.3351. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Jason F. Cole, Attorney-in-Fact
2016-07-21